Somatic mutations in facial skin from countries of contrasting skin cancer risk.

Abstract

Acknowledgements: This work was supported by grants from the Wellcome Trust to the Wellcome Sanger Institute (grant nos. 098051 and 296194). P.H.J. is supported by a Cancer Research UK Programme Grant (grant no. C609/A27326). B.A.H. acknowledges support from the Royal Society (grant no. UF130039).The incidence of keratinocyte cancer (basal cell and squamous cell carcinomas of the skin) is 17-fold lower in Singapore than the UK1-3, despite Singapore receiving 2-3 times more ultraviolet (UV) radiation4,5. Aging skin contains somatic mutant clones from which such cancers develop6,7. We hypothesized that differences in keratinocyte cancer incidence may be reflected in the normal skin mutational landscape. Here we show that, compared to Singapore, aging facial skin from populations in the UK has a fourfold greater mutational burden, a predominant UV mutational signature, increased copy number aberrations and increased mutant TP53 selection. These features are shared by keratinocyte cancers from high-incidence and low-incidence populations8-13. In Singaporean skin, most mutations result from cell-intrinsic processes; mutant NOTCH1 and NOTCH2 are more strongly selected than in the UK. Aging skin in a high-incidence country has multiple features convergent with cancer that are not found in a low-risk country. These differences may reflect germline variation in UV-protective genes

    Similar works

    Full text

    thumbnail-image